ELI LILLY & Co — Director's Dealing 2025

Aug 4, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2025-08-01

Reporting Person: Seymour Melissa (EVP, Global Quality)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-08-01	Common Stock	M	952	—	Acquired	952	Direct
2025-08-01	Common Stock	F	426.92	$740.07	Disposed	525.08	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-08-01	Restricted Stock Unit	$	M	952	Disposed		Common Stock (952)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.

F2: The restricted stock units vest in three installments, 952 on August 1, 2025, 981 on August 1, 2026, and 952 on August 1, 2027.